Talecris’ $1B IPO filing — a mad rush before the PE-boom ends?

See David Hamilton’s story at VentureBeat LifeSciences about this gutsy filing.

Next Story: Amp’d Mobile asset list *not* full of porn
Previous Story: VB Life Sciences: Your chance to sound off

Bookmark and Share
Photo of Matt Marshall

About the Author, Matt Marshall

Matt Marshall is editor and CEO of VentureBeat. Follow him on Twitter at @mmarshall, and follow VentureBeat on Twitter at @venturebeat.